171 related articles for article (PubMed ID: 21353516)
21. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype.
Lee JH; Lee YK; Kim EK; Kim TH; Huh JW; Kim WJ; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Sheen SS; Kim N; Seo JB; Oh YM; Lee SD
Respir Med; 2010 Apr; 104(4):542-9. PubMed ID: 19926461
[TBL] [Abstract][Full Text] [Related]
22. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
Akazawa M; Biddle AK; Stearns SC
Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
[TBL] [Abstract][Full Text] [Related]
23. Effects of inhaled therapies on health-related quality of life in stable chronic obstructive pulmonary disease.
Antoniu SA
Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):155-62. PubMed ID: 20384562
[TBL] [Abstract][Full Text] [Related]
24. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
Chen AM; Bollmeier SG; Finnegan PM
Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
[TBL] [Abstract][Full Text] [Related]
25. [Tiotropium, a long-acting bronchodilating agent for the treatment of COPD].
Schuurbiers OC; Schermer TR; Dekhuijzen PN; van Weel C
Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1227-32. PubMed ID: 16796173
[TBL] [Abstract][Full Text] [Related]
26. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
27. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
Beeh KM; Beier J
Adv Ther; 2010 Mar; 27(3):150-9. PubMed ID: 20411368
[TBL] [Abstract][Full Text] [Related]
28. How have we been managing chronic obstructive pulmonary disease in Australia?
Matheson MC; Abeysena C; Raven JM; Skoric B; Johns DP; Abramson MJ; Walters EH
Intern Med J; 2006 Feb; 36(2):92-9. PubMed ID: 16472263
[TBL] [Abstract][Full Text] [Related]
29. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
Suh DC; Lau H; La HO; Choi IS; Geba GP
Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
[TBL] [Abstract][Full Text] [Related]
30. Primary care of the patient with chronic obstructive pulmonary disease-part 2: pharmacologic treatment across all stages of disease.
Gross N; Levin D
Am J Med; 2008 Jul; 121(7 Suppl):S13-24. PubMed ID: 18558103
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and management of chronic obstructive pulmonary disease].
Sato N; Kanazawa M
Kyobu Geka; 2007 Aug; 60(9):841-8. PubMed ID: 17703625
[TBL] [Abstract][Full Text] [Related]
32. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of outpatients with COPD in daily practice: The E4 Spanish project.
Viejo-Bañuelos JL; Pueyo-Bastida A; Fueyo-Rodríguez A
Respir Med; 2006 Dec; 100(12):2137-43. PubMed ID: 16831541
[TBL] [Abstract][Full Text] [Related]
34. Managing stable COPD in 2009: incorporating results from recent clinical studies into a goal-directed approach for clinicians.
Rubins JB; Raci E; Kunisaki KM
Postgrad Med; 2009 Jan; 121(1):104-12. PubMed ID: 19179818
[TBL] [Abstract][Full Text] [Related]
35. [Maintenance treatment of chronic obstructive pulmonary disease].
Volla TT; Kopperud GS
Tidsskr Nor Laegeforen; 2008 Apr; 128(7):826-8. PubMed ID: 18389030
[TBL] [Abstract][Full Text] [Related]
36. New horizons in early stage COPD--improving knowledge, detection and treatment.
Decramer M; Miravitlles M; Price D; Román-Rodríguez M; Llor C; Welte T; Buhl R; Dusser D; Samara K; Siafakas N
Respir Med; 2011 Nov; 105(11):1576-87. PubMed ID: 21239156
[TBL] [Abstract][Full Text] [Related]
37. [May a COPD patient benefit from rehabilitation associated with pharmacological treatment?].
Kozielski J
Pneumonol Alergol Pol; 2012; 80(5):463-6. PubMed ID: 22926908
[TBL] [Abstract][Full Text] [Related]
38. The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD).
Davies L; Calverley PM
Br Med Bull; 2010; 93():217-27. PubMed ID: 20031934
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: A Review.
Riley CM; Sciurba FC
JAMA; 2019 Feb; 321(8):786-797. PubMed ID: 30806700
[TBL] [Abstract][Full Text] [Related]
40. Contemporary management of chronic obstructive pulmonary disease: clinical applications.
Man SF; McAlister FA; Anthonisen NR; Sin DD
JAMA; 2003 Nov; 290(17):2313-6. PubMed ID: 14600190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
